Logo for Biodesix Inc

Biodesix Investor Relations Material

Latest events

Logo for Biodesix Inc

Q4 2023

Biodesix
Logo for Biodesix

Q4 2023

1 Mar, 2024
Logo for Biodesix

Corporate Presentation

16 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Biodesix Inc

Access all reports
Biodesix, Inc. acquires and operates diagnostic companies, as well as develops and commercializes diagnostic tests in the areas of lung cancer, malignancies, and other diseases. The company provides a multi-protein blood test, which includes Nodality gene mutational panel for use in non-small-cell lung cancer (NSCLC) patients; and Biodesix Lung Reflex testing platform that analyzes circulating tumor DNA in advanced stage NSCLC patients. Biodesix, Inc. was founded in 2002 and is based in Boulder, Colorado with additional offices in California and Germany.